Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3394482
Max Phase: Preclinical
Molecular Formula: C14H10N4O
Molecular Weight: 250.26
Molecule Type: Small molecule
Associated Items:
ID: ALA3394482
Max Phase: Preclinical
Molecular Formula: C14H10N4O
Molecular Weight: 250.26
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc(=O)n2nc3nc4ccccc4cc3c2[nH]1
Standard InChI: InChI=1S/C14H10N4O/c1-8-6-12(19)18-14(15-8)10-7-9-4-2-3-5-11(9)16-13(10)17-18/h2-7,15H,1H3
Standard InChI Key: LMZMEECPLYNDOR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 250.26 | Molecular Weight (Monoisotopic): 250.0855 | AlogP: 2.03 | #Rotatable Bonds: 0 |
Polar Surface Area: 63.05 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.63 | CX Basic pKa: 1.12 | CX LogP: 2.17 | CX LogD: 2.17 |
Aromatic Rings: 4 | Heavy Atoms: 19 | QED Weighted: 0.52 | Np Likeness Score: -1.25 |
1. Karthikeyan C, Lee C, Moore J, Mittal R, Suswam EA, Abbott KL, Pondugula SR, Manne U, Narayanan NK, Trivedi P, Tiwari AK, Tiwari AK.. (2015) IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells., 23 (3): [PMID:25537531] [10.1016/j.bmc.2014.11.043] |
Source(1):